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Abstract
Purpose: To assess long-term results after single-session
alcohol sclerotherapy of symptomatic benign liver cysts
performed with maximum 20 min of exposure to alcohol.
Methods: We included 47 patients aged 32–88 years (42
women, 5 men) with 51 benign non-parasitic liver cysts
that were exposed to ethanol for 7–20 min in a single
sclerotherapy session and were followed for at least
24 months. Each cyst was emptied before injecting
ethanol (10% of cyst volume, but maximum 100 mL)
into it. The patient rotated from side to side to facilitate
contact between ethanol and the whole cyst wall. Pre-
treatment cyst volume was defined as the volume of
aspirated cyst fluid after complete emptying of the cyst.
Follow-up cyst volume was estimated based on com-
puted tomography images.
Results: Cyst volumes were 30–4900 (median 520) mL at
pre-treatment and 0–230 (median 1) mL at 24–193
(median 56) months follow-up, a reduction of 83–100%
(median 99.7%). No cyst required repeated treatment
during the follow-up. Median volume reduction was
99.7% at median 49 months of follow-up for 35 cysts
exposed to ethanol for 7–10 min vs. 99.6% at median
75 months of follow-up for 16 cysts exposed for 20 min
(p = 0.83, Mann–Whitney test). Ethanol intoxication
occurred in one patient. There were no other complica-
tions except for pain.
Conclusion: Long-term results of single-session alcohol
sclerotherapy performed with maximum 20 min of
exposure to ethanol were satisfactory with no sign of
recurrence of cyst fluid.
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Alcohol sclerotherapy may be an effective treatment for
solitary symptomatic liver cysts and for dominant
symptomatic cysts in polycystic livers [1–23]. However,
there is much variation in the time the cyst is exposed to
alcohol during the procedure (10–240 min), the volume
of alcohol applied, and in the use of one single [5–9, 13,
16, 21, 22] or multiple [3, 4, 23] sclerotherapy sessions.
These factors affect the laboratory time needed, the risk
of alcohol intoxication, and the procedural costs. Thus,
research has been recommended to standardize and
simplify the method of sclerotherapy [24, 25]. Further
studies are also needed on long-term results of scle-
rotherapy of liver cysts [9, 22, 23]. Earlier reports by
Larssen et al. suggest good results of exposing liver cysts
to alcohol for 10 or 20 min in a single sclerotherapy
session [5, 8, 9]. Here we report results of such a treat-
ment in a larger material after a minimum of two-year
follow-up. The purpose of the present study was to assess
long-term results after single-session alcohol sclerother-
apy of symptomatic benign liver cysts performed with
maximum 20 min of exposure to alcohol.
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Materials and methods
This study included 47 patients with at least 24 months
of follow-up after alcohol sclerotherapy of symptomatic
benign liver cysts performed at our hospital from 1993 to
2010 according to the procedure described below. Patient
data were recorded prospectively. Among 68 consecutive
patients treated with alcohol sclerotherapy for solitary
symptomatic liver cysts or for dominant symptomatic
cysts in polycystic livers, we excluded 17 patients fol-
lowed for <24 months and 4 patients lost to follow-up.
The follow-up protocol initially included imaging to as-
sess cyst volume within 2 months, and at 6, 12, and
24 months. We later reduced follow-up imaging during
the ﬁrst year, since it typically showed temporary recol-
lection of cyst ﬂuid that did not require treatment (see
‘‘Results’’ section). The material does not include
symptomatic polycystic livers containing only innumer-
able small cysts. Gastrointestinal surgeons at the hospital
with extensive experience in evaluating liver disease had
evaluated all patients and judged them in need of inva-
sive treatment due to symptoms from a liver cyst, e.g.,
pain, fullness, early satiety. Since 1993 at our institution,
nearly all such patients have undergone alcohol scle-
rotherapy rather than primary surgery. If the cause of
symptoms was uncertain, the cyst was emptied to test if
the symptoms vanished. We did not perform alcohol
sclerotherapy of hydatid cysts, neoplastic cysts, or cyst-
like ecstasies of the intrahepatic biliary ducts. Con-
traindications to sclerotherapy were coagulopathy,
communication between the cyst and the biliary tree or
the peritoneal cavity, and failure to aspirate injected
contrast medium from the cyst.
Sclerotherapy procedure
Premedication (50–100 mg pethidine, 0.6 mg atropine)
was used from 1993 to 2002. Since 2002, no premedica-
tion was used, but an anesthetic nurse was always present
during the procedure and provided the sedation and
analgesics needed (midazolam, alfentanil).
The patient was positioned supine on an angiographic
table. The cyst was punctured under ultrasonographic
guidance, usually with a 1.2-mm-diameter 20-cm-long
needle. If possible, the needle was inserted through 1-
3 cm of liver tissue to prevent leakage from the cyst. A
stiff guide wire was introduced and a 30-cm 7 French
(2.3 mm outer diameter) pigtail catheter (PBN Medicals,
Denmark; Argon Medical Devices, Denmark) was pu-
shed as far as possible into the cyst and ﬁxed to the skin
by adhesive tapes. After complete emptying of the cyst,
contrast material was injected and radiographs taken to
conﬁrm the position of the catheter and to exclude
communication with the biliary ducts and leakage of
contrast into the peritoneal cavity. If this occurred, or
aspiration of contrast material from the cyst failed, the
procedure was discontinued. Otherwise, ethanol was in-
jected in an amount of 10% of the cyst volume, but never
more than 100 mL. To avoid dilution of ethanol, great
care was taken to empty the cyst completely before
injecting ethanol into it. To achieve satisfactory contact
between ethanol and cyst wall, it was routine to change
the patient position from prone to supine and right to left
lateral decubitus position at least two times during the
procedure. We had tested the pigtail catheter for use with
alcohol ex vivo. The manufacturer (Argon Medical De-
vices) has tested the catheter in contact with 100%
alcohol and found no sign of degradation or leakage up
to 6 weeks (Argon Report REP1-137707, Nov 07, 2013).
Alcohol was injected using regular plastic syringes that
were usually ﬁlled with alcohol within 3 min from the
injection time.
Cysts were exposed to ethanol for 20 min (from 1993
to 1995) or 10 min (from December 1995 to June 1999).
From June 1999, cysts smaller than 1000 mL were ex-
posed to ethanol once for 10 min, whereas cysts with
volumes of at least 1000 mL were exposed to ethanol
twice in a single session, each time with 100 mL of
ethanol for 10 min. We used 96% ethanol during the
period 1993–1999 and 99% ethanol since July 1999.
Finally, all alcohol was evacuated, the cyst was irri-
gated with saline (to avoid leakage of ethanol during
withdrawal of the catheter), and the catheter was re-
moved. The patient rested in bed for 4 h and if asymp-
tomatic was discharged from the hospital the same
afternoon. The patients were observed for any signs of
alcohol intoxication during and after the procedure. The
blood alcohol level was not measured routinely, since it
was £0.3 mg/g in initial patients.
Cyst volume
Pre-treatment cyst volume was estimated as the volume
aspirated on the date of sclerotherapy when emptying the
cyst. At follow-up, one experienced radiologist measured
the three largest perpendicular cyst diameters d1, d2, and
d3 on computed tomography (CT) images, and calcu-
lated cyst volume using the formula of an ellipsoid:
volume = d1 9 d2 9 d3 9 0.523 [26].
Statistical analysis
WINPEPI version 11.60 (http://www.brixtonhealth.
com/pepi4windows.html) was applied for statistical
analysis. The Mann–Whitney test for comparing medi-
ans was used to compare pre-treatment cyst volumes,
follow-up cyst volumes, reduction of cyst volumes at
follow-up, and follow-up times between cysts exposed to
alcohol for 10 min and cysts exposed to alcohol for
20 min. All p values are two-tailed. p < 0.05 indicated
statistical significance.
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Results
Forty-seven patients (42 women and ﬁve men) aged 32–
88 (median 61) years had 51 liver cysts exposed to
ethanol for 7–20 (median 10) minutes and were followed
for 24–193 (median 56) months. Six cysts in ﬁve patients
were in polycystic livers and 45 cysts in 42 patients were
not.
In the total sample, median cyst volumes were
520 mL at pre-treatment and 1 mL—or median 99.7%
smaller—at the last follow-up (Table 1). None of the 51
treated cysts required repeated treatment during the re-
ported follow-up period due to insufficient effect of the
sclerotherapy.
Median volume reduction was 99.7% for 35 cysts
exposed to ethanol for 7–10 min vs. 99.6% for 16 cysts
exposed to alcohol for 20 min (p = 0.83, Table 1). Cysts
exposed for 7–10 min vs. 20 min did not differ signifi-
cantly in volume at follow-up (p = 0.28) or time to
follow up (p = 0.24) (Table 1), but were originally
smaller (median 394 vs. 1525 mL, p = 0.004; Table 1).
This was expected, since cysts ‡1000 mL were exposed to
alcohol for 20 min from 1999. Seven (of 18)
cysts ‡1000 mL were exposed to alcohol for 7–10 min,
and were 88–100% (median 99%) smaller at 78–
193 months (median 11 years) of follow-up.
We followed 11 cysts in 10 patients for more than
10 years. These cysts were 88–100% (median 100%)
smaller at 127–193 months (median 12 years) of follow-
up.
CT performed within three months after sclerother-
apy of 17 cysts in 16 patients showed recollection of cyst
ﬂuid in all. The ﬂuid later diminished in all patients
without therapy (Fig. 1). At the first follow-up at 0.3–3
(median 1) months, the 17 cysts measured 9–100% (me-
dian 39%) of their original volume of 30–4900 (median
1250) mL. All 17 cysts then shrank during the first year.
Cyst volume was 0–30% (median 5%) of the original
volume at 4.5–6 months (data on 13 cysts) and 0–36%
(median 2%) at 10–14 months (data on 13 partly differ-
ent cysts). At the last follow-up, the 17 cysts had shrank
to 0–12% (median 0.3%) of their initial volume.
There was one major procedure related complication:
ethanol intoxication in a 77-year-old woman following
exposure of one 4900 mL cyst to 100 mL alcohol for
10 min twice in one session (respiratory failure, alcohol
smell from breath, blood alcohol concentration 1.95 mg/
g; morphine antidote given, uneventful recovery; cyst
disappeared at 77 months of follow-up). A minor com-
plication was abdominal pain during the procedure. This
was no longer a problem after we abandoned premedi-
cation and started to use analgesics according to indi-
vidual needs and to irrigate the cysts with saline before
removing the catheter, preventing remnants of ethanol
within it to cause pain during removal.
Discussion
In this study, liver cysts exposed to alcohol for a
maximum of 20 min in one treatment session were 83–
100% (median 97.7%) smaller at 2–16 years of follow-
up. No cyst required repeated treatment during the
follow-up. Even for large cysts, we used maximum
100 mL of alcohol once or twice in a single session. The
procedure caused alcohol intoxication in one patient
(2%) with an uneventful recovery. The brief exposure of
liver cysts to a relatively small amount of alcohol was
thus safe and prevented recurrence of cyst ﬂuid in the
long term.
Alcohol should be in contact with the whole cyst
cavity during the treatment in order to ﬁx the epithelial
cells and disable their ability to secret ﬂuid [1, 15, 21, 27].
Alcohol can also induce a temporary inflammatory
reaction in a cystic wall deprived of vital epithelium [28].
This may explain the transitory re-accumulation of cyst
fluid seen in the present and other studies [5, 6]. Impor-
tantly, cyst fluid re-accumulated within three months but
diminished without treatment.
Some parts of our procedure may be essential when
exposing liver cysts to limited amounts of alcohol for a
short time. First, in order to avoid dilution of alcohol
concentration, it is important to empty the cyst com-
pletely before injecting alcohol into it. Second, after
alcohol injection, the patient should rotate from side to
side to facilitate contact between alcohol and every part
of the cyst, especially when the cyst is large and may have
a multifolded wall when emptied. Third, to make it easier
for the patient to co-operate and change position, we













Total sample 61 (32–88) 42/5 520 (30–4900) 1 (0–230) 99.7 (83–100) 56 (24–193)
Alcohol exposure
10 mina (35 cysts, 32 patientsb) 61 (43–88) 27/5 394 (30–4110) 1 (0–230) 99.7 (83–100) 49 (24–193)
20 min (16 cysts, 16 patientsb) 68 (32–86) 15/1 1525 (200–4900) 5 (0–188) 99.6 (91–100) 75 (24–171)
Values are median (range) except values for women/men
a Includes two cysts exposed for 7 and 8 min, respectively
b One patient (a man)is included in both alcohol exposure groups because he had one cyst exposed to alcohol for 10 min and another cyst exposed to
alcohol for 20 min
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advise effective pain management as needed during the
procedure rather than general premedication.
We found good results of exposing liver cysts to
alcohol for only 10 min, based on treatment of 35 cysts.
Larssen et al. have previously reported promising results
of exposing liver cysts to ethanol for 10 min in a study
comprising only 10 cysts [8]. The present findings suggest
that an alcohol exposure time of 10 min may be equally
effective as an alcohol exposure time of 20 min in many
patients. An alcohol exposure time of 10 min may be
effective also for cysts >1000 mL, but was used in only
seven such cysts in our study. In their recent retrospective
study, Akhan et al. reported successful results of expos-
ing 39 liver cysts to alcohol for 10 min, but all cysts in
their material were <700 mL [22]. Therefore, the effec-
tiveness of exposing cysts >1000 mL to alcohol for
10 min needs further validation.
Provided the sclerotherapy remains effective, briefer
exposure to alcohol during the procedure may be
advantageous by reducing alcohol intoxication risk,
interventional laboratory time, and duration of hospi-
talization. In studies of liver cysts exposed to alcohol for
60 min [2, 6], all patients had elevated alcohol levels in
the blood, and both prolonged exposure and increased
volume of alcohol increased the risk of alcohol intoxi-
cation.
Our study had strengths and limitations. It repre-
sented day-to-day radiological work, making the results
highly relevant to clinical practice. Patients and data
were noted prospectively, avoiding retrospective identi-
ﬁcation of patients in medical records. The follow-up
period was longer and the material slightly larger (24–
193 months, median 56 months; 51 cysts) than in recent
studies by Akhan et al. [22] (4–173 months, median
38 months; 39 cysts) and Jang et al. [23] (12–106 months,
mean 33 months; 43 cysts). We used CT and the same
observer (not ultrasonography performed by different
observers) to estimate cyst volumes at follow-up by
means of a validated method for estimating organ vol-
umes [26, 29]. However, we did not report on course of
Fig. 1. A 1750 mL liver cyst in a 71-year-old woman before
sclerotherapy (A). Recollection of 850 mL cyst fluid was observed
24 days after sclerotherapy (B). However, the cyst (long white
arrows) was smaller at 6 months without repeated sclerotherapy
(C), had shrank to 99% of its pre-treatment size at 17 months (D),
and showed no signs of recurrence at 193 months post treatment
(E). An adjacent cyst (short white arrow) had grown slowly to
65 mL at 193 months post treatment (E).
T. B. Larssen et al.: Single-session alcohol sclerotherapy of symptomatic liver 1779
symptoms, except that no cyst required repeated treat-
ment. Since prior research had shown good effect of re-
duced cyst volume on symptoms [2, 5–8], we rather
focused on whether our treatment procedure ensured
small cyst volumes in the long term. As part of the daily
clinical practice, we adjusted the procedure slightly dur-
ing the study period based on accumulated experience.
We reduced the alcohol exposure time from 20 to 10 min
based on good results in three initial patients in whom
the procedure had to be discontinued due to pain. We
later exposed cysts >1000 mL for 20 min (10 min twice)
to be more certain of effect. However, our study design
was not optimal for comparing results between 10 and
20 min of alcohol exposure, which would have required a
randomized trial.
In conclusion, the employed procedure of alcohol
sclerotherapy of liver cysts varies considerably between
institutions. This study showed that there is a durable
response to sclerotherapy performed with 10–20 min of
exposure to ethanol in a single session.
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